Novel solid lipid nanoparticles as carriers for oral administration of insulin

Pharmazie

Volumn 64, Issue 9, 2009, Pages 574-578

  Zhang, Zhenhai ^a   Lv, Huixia ^a   Zhou, Jianping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CELL PENETRATING PEPTIDE; INSULIN; OCTAARGININE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; DIFFUSION; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; ENCAPSULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; ELECTROCHEMISTRY; EMULSIONS; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINAL ABSORPTION; LIPOSOMES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 75749129504     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9051     Document Type: Article

References (23)

1. Chung SK, Maiti KK, Lee WS (2008) Recent advances in cell-penetrating, non-peptide molecular carriers. Int J Pharm 354: 16-22.
2. Cui F, Shi K, Zhang L, Tao A, Kawashima Y (2006) Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release114: 242-250.
3. Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the antennapedia homeodomain translocates through biological membranes. J Biol Chem 269: 10444-10450.
4. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91: 664-668.
5. Futaki S, Goto S, Suzuki T, Nakase I, Sugiura Y (2003) Structural variety of membrane permeable peptides. Curr Protein Pept Sci. 4 : 87-96.
6. Garcia-Fuentes M, Torres D, Alonso MJ (2002) Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B: Biointerfaces 27: 159-168.
7. Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T (1998) Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm 45: 41-48.
8. Kosuge M, Takeuchi T, Nakase I, Jones AT, Futaki S (2008) Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug Chem 19: 656-664.
9. Komatsu H, Kitajima A, Okada S (1995) Pharmaceutical characterization of commercially available intravenous fat emulsions : estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull 43: 1412-1415.
10. Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, Zhang Q, He Q, Zhang Z (2008) Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 356: 333-344.
11. Meade BR, Dowdy SF (2007) Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 59: 134-140.
12. Mehnert W, Mader K (2001) Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 47: 165-169.
13. Morishita M, Peppas NA (2006) Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11: 905-910.
14. Müller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47: 3-19.
15. Müller RH, Keck CM (2004) Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113: 151-170.
16. Norris DA, Puri N, Sinko PJ (1998) The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev 34: 135-154.
17. Owens DR, Zinman B, Bolli G (2003) Alternative routes of insulin delivery. Diabet Med 20 : 886-898.
18. Siekmann B, Westesen K (1996) Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsion. Eur J Pharm Biopharm 43: 104-109.
19. Torchilin VP (2008) Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60: 548-558.
20. Trehin R, Merkle HP (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 58: 209-223.
21. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2000) The design, synthesis and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters, Proc Natl Acad Sci USA 97: 13003-13008.
22. Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X (2006) Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 327: 153-159.
23. Zorko M, Langel U (2005) Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Deliv Rev 57: 529-545.